Ledger.Open graph →

SEC Form D · filed January 29, 2016

Tarveda Therapeutics, Inc

Offering

$38.0M

Sold

$25.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WATERTOWN, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Nilesh C. Kumar · Watertown, MADirector Leila C. Alland · Watertown, MAExec Robert S. Langer · Watertown, MADirector · Promoter Aymeric S. Sallin · Watertown, MADirector Omid C. Farokhzad · Watertown, MADirector · Promoter Richard C. Wooster · Watertown, MAExec Frank C. Torti · Watertown, MADirector Edwin M. Kania · Watertown, MADirector James J. Barrett · Watertown, MADirector Andrew J. Fromkin · Watertown, MAExec · Director Andrew Saltoun · San Francisco, CAExec · Director Justin Jory · San Francisco, CAExec William Adams · San Francisco, CADirector · Promoter Michael D. Weinberg · Dallas, TXDirector Nancy P. Carlson · Dallas, TXDirector Mark Phelps · PHOENIX, AZDirector Theodore Haig · PHOENIX, AZDirector Barry Fernando · PHOENIX, AZExec · Director David Hirschfeld · PHOENIX, AZExec · Director · Promoter John S. Koudounis · Naperville, ILExec · Director · Promoter Thomas E. Herman · Naperville, ILDirector Freshun D. Flowers · Tuscaloosa, ALDirector Brian A. Meyer · New York, NYDirector Thomas Shandell · Greenwich, CTDirector Daniel Spinner · Greenwich, CTDirector Jeffrey Bisberg · Austin, TXExec Gregory S. Oberholtzer · Chicago, ILDirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗